GRAIL Inc.
GRAL
Rank in Stocks
#3038
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Share Price
$132.85
Last synced: 2026-10-21
Market Cap
$5.93B
Change (1 day)
6.56%
Change (1 year)
66.56%
Country
US
Trade GRAIL Inc. (GRAL)
Category
Healthcare
Number of shares outstanding for GRAIL Inc. (GRAL)
Number of shares outstanding as of October 2026: 0
According to GRAIL Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of October 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for GRAIL Inc. (GRAL) from 2018 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2025 | 36.75M | 15.21% |
| 2024 | 31.90M | 2.73% |
| 2023 | 31.05M | 0.00% |
| 2022 | 31.05M | 0.00% |
| 2021 | 31.05M | -74.89% |
| 2020 | 123.67M | 0.39% |
| 2019 | 123.19M | 7.93% |
| 2018 | 114.14M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
